Copia Scientific

Copia Scientific provides innovative laboratory automation solutions, focusing on microplate-based instrumentation to enhance laboratory workflows and improve efficiency. Copia Scientific, founded in 2021 and headquartered in San Diego, US, specializes in laboratory automation solutions. The company was formed through the merger of BioSurplus, Inc. and BioDirection, Inc.

, aimed at creating the nation’s largest, non-OEM lab equipment reseller and service provider. Bill VanDeWeghe serves as the CEO, leading the company in its mission to support diverse clientele in North America and Europe. The company has engaged in one investment deal, with the most recent transaction occurring on August 19, 2021. Copia Scientific specializes in providing a comprehensive range of laboratory automation solutions, primarily focusing on microplate-based instrumentation.

Their core offerings include advanced liquid handling systems, robotic arms, microplate dispensers, and integrated lab automation systems designed to enhance productivity and efficiency in laboratory workflows. These products aim to automate manual protocols, translating them into streamlined, automated methods that improve accuracy and minimize operational costs. The company serves a diverse clientele across various sectors, including academic research institutions, pharmaceutical companies, and biotechnology firms, primarily in North America and Europe. By catering to these markets, Copia Scientific addresses the needs of end-users who require reliable and efficient laboratory solutions to facilitate their research and development processes.

Copia Scientific generates revenue through direct sales of their laboratory equipment and services, structured around both individual product transactions and service contracts. Clients typically engage in transactions involving the purchase of equipment, which may include flagship products like the Hamilton Star and Tecan EVO-100, and subscribe to ongoing maintenance services provided by factory-trained technicians. This B2B model enables the company to build long-term relationships with clients, ensuring continual support and integration of their lab systems. The company also offers trade-in and upgrade options for existing equipment, reinforcing customer loyalty and facilitating sustained revenue streams through repeat business.

Pricing for these services and products is structured to reflect the quality and expertise offered, aligning with the high standards expected in laboratory settings. Copia Scientific plans to leverage its recent merger to expand its product offerings and market presence. The company is focusing on designing new products tailored for evolving laboratory needs, with anticipated launches in the upcoming quarters. Their strategy includes targeting additional markets in North America and Europe, aiming for expansion by the end of 2023.

The funding from the recent merger will be utilized to support these initiatives, enhancing their capacity as the largest non-OEM lab equipment reseller and service provider.